A clinical guide to the management of Graves' disease with radioactive iodine. (Record no. 6189)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02270nam a22003257a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 210218s19951995 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1530-891X |
| 024 ## - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.4158/EP.1.3.205 [doi] |
| 024 ## - OTHER STANDARD IDENTIFIER | |
| Standard number or code | S1530-891X(20)40988-7 [pii] |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | Ovid MEDLINE(R) |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) | |
| PMID | 15251595 |
| 245 ## - TITLE STATEMENT | |
| Title | A clinical guide to the management of Graves' disease with radioactive iodine. |
| 251 ## - Source | |
| Source | Endocrine Practice. 1(3):205-12, 1995 May-Jun. |
| 252 ## - Abbreviated Source | |
| Abbreviated source | Endocr Pract. 1(3):205-12, 1995 May-Jun. |
| 253 ## - Journal Name | |
| Journal name | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Year | 1995 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Manufacturer | FY1995 |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] | |
| Publication status | ppublish |
| 266 ## - Date added to catalog | |
| Date added to catalog | 2021-02-18 |
| 520 ## - SUMMARY, ETC. | |
| Abstract | More than 50 years have passed since radioactive iodine (RAI) was initially demonstrated as a therapeutic modality for the treatment of Graves' Disease. Today, more than a million patients have been treated with RAI. RAI is considered safe and highly effective. Its side-effect profile, ease of administration, and relative cost make RAI the treatment of choice for Graves' Disease of thyroidologists in this country. Questions continue to be raised as to which patients will benefit most from RAI therapy. Marked differences still exist between the practice preferences of thyroidologists as to whom, when, and how to treat with RAI. Factors that influence patient selection for RAI include age, the presence of pre-existing ophthalmopathy, lifestyle, history of previous treatment failure, and goiter size. Treatment goals, dosimetry, use of thionamides prior to therapy, safety recommendations following therapy, and prophylactic therapy with glucocorticoids for patients with ophthalmopathy highlight are some of the controversial issues facing the endocrinologist treating Graves' Disease with RAI. This symposium article reviews the current management of Graves' Disease with RAI. |
| 546 ## - LANGUAGE NOTE | |
| Language note | English |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | IN PROCESS -- NOT YET INDEXED |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME | |
| Institution | MedStar Washington Hospital Center |
| 656 ## - INDEX TERM--OCCUPATION | |
| Department | Medicine/Endocrinology |
| 657 ## - INDEX TERM--FUNCTION | |
| Medline publication type | Journal Article |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Local Authors | Levetan, Claresa |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Local Authors | Wartofsky, Leonard |
| 790 ## - Authors | |
| All authors | Levetan C, Wartofsky L |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Journal Article |
| Item type description | Article |
| Withdrawn status | Lost status | Damaged status | Not for loan | Collection | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MedStar Authors Catalog | MedStar Authors Catalog | 02/18/2021 | 15251595 | 15251595 | 02/18/2021 | 02/18/2021 | Journal Article |